for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up
Healthcare

BRIEF-Innovent Biologics Says China's NMPA Accepted Supplemental New Drug Application For Tyvyt

April 24 (Reuters) - Innovent Biologics Inc:

* CHINA’S NMPA ACCEPTED SUPPLEMENTAL NEW DRUG APPLICATION FOR TYVYT Source text for Eikon: Further company coverage:

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up